Cardiomac India Private Limited

Cardiomac India Private Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U51909DL2015PTC278542 Incorporated 30 March 2015 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company healthcare MSME · Small
Data last updated
Revenue · FY 2024
₹21.24 Cr
▲ 5% YoY
Net profit · FY 2024
₹67,860
Net margin 0%
EBITDA · FY 2024
₹31.83 Lakh
EBITDA margin 1.5%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹9 Lakh
Issued & subscribed
Open charges
₹7.16 Cr
Satisfied ₹1.36 Cr
Company age
11 yrs
Est. 2015
Employees · EPFO
19
Provident fund records

About Cardiomac India Private Limited

Data last updated:

Cardiomac India Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 30 March 2015 and has been in existence for over 11 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2015PTC278542. Its GSTIN is 08AAFCC9845D1ZI (Rajasthan). The company holds 4 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹9 Lakh. It is led by directors Rahul Yadav and Sunita Yadav.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Unit No – 301 Third Floor Aggarwal Square Plot No – 10 Pkt – 4 Sector – 11 Dwarka New, Delhi – 75, New Delhi, Delhi, India – 110075.

As per the financials filed for FY 2024, the company reported a revenue of ₹21.24 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹67,860 (net margin 0%) and EBITDA of ₹31.83 Lakh (EBITDA margin 1.5%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years and 34% over five years.

The company has about 19 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Cardiomac. As per MCA filings, the company has open charges of ₹7.16 Cr and satisfied charges of ₹1.36 Cr on record. Court records list 5 cases involving the company, including 5 filed against it; 2 cases are pending. The company has 1 deal on record (1 funding round), with disclosed funding of ₹80 Lakh; the latest was in August 2018. Its 3 peer companies in the Healthcare industry (Medical and Laboratory Equipment), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 1 larger and 2 smaller; the largest is Kriya Medical Technologies Private Limited with revenue of ₹21.37 Cr.

Cardiomac India Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-02-0002030). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cardiomacinc.com.

Company details

CIN U51909DL2015PTC278542
Registration Number 278542
Incorporation Date 30 March 2015
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-RJ-02-0002030

Recognitions & Rankings of Cardiomac India

MSME (Udyam registered) Ministry of MSME
Category
Small (2022-23)
Udyam number
UDYAM-RJ-02-0002030

Contact details

Cardiomac India Private Limited's registered office is in New Delhi, Delhi. Its website is cardiomacinc.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Unit No – 301 Third Floor Aggarwal Square Plot No – 10 Pkt – 4 Sector – 11 Dwarka New, Delhi – 75, New Delhi, Delhi, India – 110075
  • Industry
    Healthcare, Medical & Laboratory Equipment

To see the full contact details of Cardiomac India Private Limited, buy the company report.

Comprehensive company report
Cardiomac India Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Cardiomac India operates one associated brand: Cardiomac. Each brand links to its own profile.

BrandDescriptionWebsite
Medical device manufacturing, focusing on vascular access products and equipment in India.cardiomacinc.com

Business activity

The main business activity of Cardiomac India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Cardiomac India Private Limited, buy the company report.

Financials of Cardiomac India Private Limited

FY 2024 filings available

Cardiomac India Private Limited reported revenue of ₹21.24 Cr (up 5% YoY) for FY 2024.

Revenue · FY 2024
₹21.24 Cr ▲ 5%
Net profit · FY 2024
₹67,860 margin 0%
EBITDA · FY 2024
₹31.83 Lakh margin 1.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 23%
5 years · compounded
▲ 34%
EBITDA CAGR growth
1 year
▼ 40%
3 years · compounded
▼ 19%
5 years · compounded
▼ 11%

Revenue has grown at a compounded annual rate (CAGR) of 34% over five years, including 5% growth in the latest year. EBITDA fell 40% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹31.83 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹67,860
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin1.5%
Net Profit Margin0%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Cardiomac India Private Limited, buy the company report.

Board of directors of Cardiomac India Private Limited

Cardiomac India has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rahul YadavDirector04 Jun 20215 Years 5 MonthsCurrent
Sunita YadavDirector04 Jun 20215 Years 5 MonthsCurrent

Peer comparison

Cardiomac India Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Medical and Laboratory Equipment), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Kriya Medical Technologies Private Limited₹21.37 Cr (FY 2025)15.0%Thiruvallur, Tamil Nadu, India
Cardiomac India Private Limitedthis company₹21.24 Cr (FY 2024)₹67,8600%5.0%19New Delhi, Delhi, India
Glowsun India Labs Private Limited₹21.2 Cr (FY 2024)11.0%Dehradun, Uttarakhand, India
Vanguard Diagnostics Private Limited₹20.87 Cr (FY 2025)-18.0%New Delhi, Delhi, India

To see the full peer comparison of Cardiomac India Private Limited, buy the company report.

Auditor

Cardiomac India Private Limited is audited by K VIPIN & ASSOCIATES for the financial year 2022.

Auditor firmFinancial yearFirm registration number
K VIPIN & ASSOCIATESFY 2022038441N

Shareholding

The shareholding of Cardiomac India Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Cardiomac India Private Limited, buy the company report.

Charges & borrowings

Open charges
₹7.16 Cr
Satisfied charges
₹1.36 Cr
Breakdown by lending institutions
Others₹3.61 Cr
Bank of India₹1.79 Cr
State Bank of India₹1.75 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
24 Jun 2024100957344Others₹3.4 CrOpen
21 Sep 2023100799090State Bank of India₹1.75 CrOpen
22 Mar 2019100249778Others₹21.09 LakhOpen
20 Sep 2018100216946Bank of India₹1.79 CrOpen
31 Oct 2020100435698Others₹52 LakhSatisfied

To see the full charge records of Cardiomac India Private Limited, buy the company report.

Total charge records: 7 View all charges

Deals & funding

Cardiomac India Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹80 Lakh; the latest was in August 2018.

Total deals
1
Funding round
1
Disclosed funding
₹80 Lakh

Deals on record (1 of 1)

WhenDealAmountParties
Aug 2018Funding round₹80 LakhInvestors: an individual

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Cardiomac India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Cardiomac India Private Limited has a workforce of 19 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.

Employee count
19
Active EPFO establishments
1
Employee growth
11.76%

GST

Cardiomac India has 4 GST registrations: 1 active and 3 cancelled or inactive.

Total GSTINs
4
Active
1
Cancelled / inactive
3
GSTINStateStatusRegistered on
08AAFCC9845D1ZIRajasthanActive25 Jan 2019

To see the full GST registrations and return filing status of Cardiomac India Private Limited, buy the company report.

Recent activity

Cardiomac India Private Limited has 6 board changes on record since 2021: 2 appointments and 4 cessations. The latest: Rahul Yadav ceased to be Additional Director on 30 Nov 2021.

Charges
A charge with Others of Rs. 340.00 Lakh registered on 24 Jun 2024 with Charge ID 100957344 was modified on 30 Jun 2025.
AGM
Cardiomac India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge registered on 31 Oct 2020 via Charge ID 100435698 with Others was fully satisfied on 05 Sep 2024.
Charges
A charge registered on 31 Oct 2020 via Charge ID 100435701 with Others was fully satisfied on 05 Sep 2024.
Charges
A charge registered on 31 Oct 2020 via Charge ID 100436326 with Others was fully satisfied on 05 Sep 2024.
Charges
A charge with Others amounted to Rs. 340.00 Lakh with Charge ID 100957344 was registered on 24 Jun 2024.
Filing
Cardiomac India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi I.
Charges
A charge with State Bank Of India amounted to Rs. 175.00 Lakh with Charge ID 100799090 was registered on 21 Sep 2023.
Ceased
Rahul Yadav ceased to be Additional Director.
Ceased
Sunita Yadav ceased to be Additional Director.
Ceased
Chandan Kumar ceased to be Director.
Ceased
Kanchan ceased to be Director.

9 earlier events are in the company report.

Frequently asked questions

Cardiomac India is an active private limited company based in New Delhi, Delhi, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 30 March 2015 (11+ years old) and is registered under CIN U51909DL2015PTC278542.

Cardiomac India has 2 current directors:

The latest financial statements of Cardiomac India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Cardiomac India is 08AAFCC9845D1ZI, registered in Rajasthan. The company has 4 GST registrations in all, of which 1 is active and 3 are cancelled or inactive.

The CIN (Corporate Identification Number) of Cardiomac India is U51909DL2015PTC278542. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Cardiomac India has 5 court cases on record: 5 filed against it. 2 are pending.

Cardiomac India was incorporated on 30 March 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.

Cardiomac India has 1 deal on record (1 funding round), with disclosed funding of ₹80 Lakh; the latest was in August 2018.

The peers of Cardiomac India by revenue are Kriya Medical Technologies Private Limited, Glowsun India Labs Private Limited, Vanguard Diagnostics Private Limited, all in the Healthcare industry (Medical and Laboratory Equipment), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Rahul Yadav ceased to be Additional Director on 30 Nov 2021. Sunita Yadav ceased to be Additional Director on 30 Nov 2021. Chandan Kumar ceased to be Director on 05 Jun 2021. Cardiomac India has 6 board changes on record in total.

Yes, Cardiomac India is registered as a small enterprise under Udyam registration (number: UDYAM-RJ-02-0002030).